External quality assessment scheme for influenza antiviral susceptibility for the European Reference Laboratory Network for Human Influenza – 2015
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This was the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008. Overall results for the exercise were encouraging. Twenty-four laboratories from 19 European countries participated in the exercise while fourteen laboratories opted out because they did not perform assays capable of determining antiviral susceptibility. This represents increased capacity (24 laboratories) across the network, compared to the first EQA exercise in 2010 (20 laboratories).Phenotypic antiviral susceptibility results were encouraging. Eighteen of the 24 laboratories (75%) returned phenotypic results, with only nine incorrect results out of a total of 261 (3.4%).
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.
Influenza communication guide: How to increase influenza vaccination uptake and promote preventive measures to limit its spread
21 Nov 2019 - The influenza vaccination communication guide provide advice, guidance and campaign materials to support national influenza vaccination campaigns with the purpose of increasing the influenza vaccination uptake in the EU Member States.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
5 Sep 2019 - This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.